123 related articles for article (PubMed ID: 6224466)
1. [Clinical evaluation of neocarzinostatin in digestive system cancer. 2. Clinical studies on the administration of neocarzinostatin in advanced and recurrent carcinoma of the pancreas].
Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1872-7. PubMed ID: 6224466
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of neocarzinostatin in digestive system cancer. 1. Administration of neocarzinostatin in advanced and recurrent carcinoma of the stomach].
Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1866-71. PubMed ID: 6224465
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with neocarzinostatin (NCS) and other antitumor agents for advanced carcinoma of the digestive organs--improved clinical effect with NFO therapy].
Maeta M; Koga S; Shimizu N; Osaki Y; Hirai Y; Kato K; Masaki T; Maeta K; Kishimoto H; Watanabe S; Sugihara T; Iwasaki T; Tasaki M; Abe J; Yamashiro N
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1742-8. PubMed ID: 6223587
[TBL] [Abstract][Full Text] [Related]
4. [Use of arterial infusion of neocarzinostatin with or without combination chemotherapy as a treatment of carcinoma of the prostate].
Yuasa M; Numata A; Tanaka T; Kawanishi Y; Yamamoto A; Imagawa A
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2325-30. PubMed ID: 2425748
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract].
Kikuchi K
Gan To Kagaku Ryoho; 1982 Apr; 9(4):716-21. PubMed ID: 6764110
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of arterial infusion chemotherapy with neocarzinostatin on inoperable hepatoma].
Sasaki Y; Fujita S; Yoshioka H; Takimoto C; Mitsutani N; Koizumi T
Gan To Kagaku Ryoho; 1982 May; 9(5):898-905. PubMed ID: 6307185
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer.
Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Okajima K
Bull Osaka Med Sch; 1981 Oct; 27(2):65-78. PubMed ID: 6295535
[No Abstract] [Full Text] [Related]
8. [Preoperative administration of antineoplastic agents against gastric cancer. V. Clinical evaluation of combined chemotherapy with neocarzinostatin (NCS) and 5-fluorouracil (combined NF therapy) (author's transl)].
Okada K; Kitade F; Mabuchi A; Osawa N; Yasuda M; Kawashima Y; Yagi A; Yamada S; Sakuramoto K; Okajima K; Kita R; Sumida T; Kasagawa O
Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):834-41. PubMed ID: 159328
[No Abstract] [Full Text] [Related]
9. [Neocarzinostatin therapy of advanced renal cell carcinoma].
Tari K; Satake I; Kojima S; Tsujii T; Yonese J
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
[TBL] [Abstract][Full Text] [Related]
10. [Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
Ogura T; Hiramatsu Y; Araki H; Kojima Y; Nakagawa A; Nakagawa M; Kamiyama Y; Shirasaka T
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():433-8. PubMed ID: 8849289
[TBL] [Abstract][Full Text] [Related]
11. [Clinical studies of cancer chemotherapy combined with angiotensin-II (ANG-II)].
Takahashi N; Kunii Y; Kanno H; Kikuchi K
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1640-5. PubMed ID: 6820924
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of intra-peritoneal and intra-venous injection of monoclonal antibody A7-NCS conjugates against peritoneal dissemination of the gastric cancer].
Kuriu Y; Otsuji E; Okamoto K; Ichikawa D; Fujiwara H; Ochiai T; Sakakura C; Ueda Y; Sonoyama T; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1842-3. PubMed ID: 15553733
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on chemo-immunotherapy for advanced and recurrent carcinoma of the breast].
Kikuchi K; Takahashi N
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1476-81. PubMed ID: 3925888
[TBL] [Abstract][Full Text] [Related]
16. [Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
Shirasaka T; Yamamitsu S; Tsuji A; Terashima M; Hirata K
Gan To Kagaku Ryoho; 2000 Jun; 27(6):832-45. PubMed ID: 10897209
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
18. [Intra-operative administration of neocarzinostatin into the duodenal subserosa and levels found in the regional lymph nodes in pancreato-duodenal cancer].
Hase Y; Kondo T; Nakagawa H; Matsumoto T; Maekawa T; Sakakibara N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3119-24. PubMed ID: 2960268
[TBL] [Abstract][Full Text] [Related]
19. [Effect of monoclonal antibody-neocarzinostatin conjugate for gastric cancer with peritoneal dissemination--comparison between early and late administration].
Okamoto K; Otsuji E; Toma A; Kobayashi S; Kitamura K; Yamaguchi T; Yamagishi H
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1508-10. PubMed ID: 11707966
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]